Mizuho Initiates Coverage On Chemours with Neutral Rating, Announces Price Target of $25
Portfolio Pulse from Benzinga Newsdesk
Mizuho analyst John Roberts has initiated coverage on Chemours (NYSE:CC) with a Neutral rating and set a price target of $25.
June 07, 2024 | 10:40 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Mizuho has initiated coverage on Chemours with a Neutral rating and a price target of $25. This suggests that the analyst does not expect significant movement in the stock price in the near term.
The Neutral rating indicates that the analyst does not foresee significant upside or downside in the stock price. The price target of $25 suggests that the stock is fairly valued at its current price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100